# Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm

> **NCT06432452** · PHASE2,PHASE3 · ENROLLING_BY_INVITATION · sponsor: **Radboud University Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Spasm

## Interventions

- **DRUG:** Endothelin Receptor Antagonist
- **OTHER:** Placebo control

## Key facts

- **NCT ID:** NCT06432452
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-11-11
- **Primary completion:** 2026-06-15
- **Final completion:** 2026-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-11-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06432452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06432452, "Efficacy of Endothelin Receptor Antagonism in Coronary Artery Spasm". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06432452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*